drug · antibody
patient view →omalizumab biosimilar
Marketedupdated 2mo agoby Kashiv BioSciences LLC🔗 ChEMBL
Approvedcommunity read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 27 investigational indications.
indications
investigational
Asthma
targets
Immunoglobulin heavy constant epsilon
all catalysts(2)
approval · 2
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that